Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Nexavar TM
Active ingredients: sorafenib
What it is used for
Hepatocellular carcinoma. NEXAVAR is indicated for the treatment of patients with advanced hepatocellular carcinoma (HCC). Renal cell carcinoma. NEXAVAR is indicated for the treatment of patients with advanced renal cell carcinoma (RCC). Differentiated Thyroid carcinoma. NEXAVAR is indicated for the treatment of patients with locally advanced or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 25 degrees Celsius
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Red, round, biconvex, film-coated tablets marked with BAYER cross on one side and "200" on the reverse.
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient sorafenib
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
